IRIS Accounts Production v24.3.2.46 04345156 Board of Directors 1.10.23 30.9.24 30.9.24 true false true true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh043451562023-09-30043451562024-09-30043451562023-10-012024-09-30043451562022-09-30043451562022-10-012023-09-30043451562023-09-3004345156ns15:EnglandWales2023-10-012024-09-3004345156ns14:PoundSterling2023-10-012024-09-3004345156ns10:Director12023-10-012024-09-3004345156ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3004345156ns10:FRS1022023-10-012024-09-3004345156ns10:Audited2023-10-012024-09-3004345156ns10:LargeCompaniesRegimeForDirectorsReport2023-10-012024-09-3004345156ns10:LargeCompaniesRegimeForAccounts2023-10-012024-09-3004345156ns10:FullAccounts2023-10-012024-09-3004345156ns10:OrdinaryShareClass12023-10-012024-09-3004345156ns10:Director22023-10-012024-09-3004345156ns10:Director32023-10-012024-09-3004345156ns10:Director42023-10-012024-09-3004345156ns10:CompanySecretary12023-10-012024-09-3004345156ns10:RegisteredOffice2023-10-012024-09-3004345156ns5:CurrentFinancialInstruments2024-09-3004345156ns5:CurrentFinancialInstruments2023-09-3004345156ns5:Non-currentFinancialInstruments2024-09-3004345156ns5:Non-currentFinancialInstruments2023-09-3004345156ns5:ShareCapital2024-09-3004345156ns5:ShareCapital2023-09-3004345156ns5:CapitalRedemptionReserve2024-09-3004345156ns5:CapitalRedemptionReserve2023-09-3004345156ns5:RetainedEarningsAccumulatedLosses2024-09-3004345156ns5:RetainedEarningsAccumulatedLosses2023-09-3004345156ns5:ShareCapital2022-09-3004345156ns5:RetainedEarningsAccumulatedLosses2022-09-3004345156ns5:CapitalRedemptionReserve2022-09-3004345156ns5:RetainedEarningsAccumulatedLosses2022-10-012023-09-3004345156ns5:CapitalRedemptionReserve2022-10-012023-09-3004345156ns5:RetainedEarningsAccumulatedLosses2023-10-012024-09-3004345156ns5:CapitalRedemptionReserve2023-10-012024-09-3004345156ns5:FurnitureFittings2023-10-012024-09-3004345156ns5:OwnedAssets2023-10-012024-09-3004345156ns5:OwnedAssets2022-10-012023-09-3004345156112023-10-012024-09-3004345156112022-10-012023-09-300434515612023-10-012024-09-300434515612022-10-012023-09-300434515622023-10-012024-09-300434515622022-10-012023-09-3004345156ns10:OrdinaryShareClass12022-10-012023-09-3004345156ns5:FurnitureFittings2023-09-3004345156ns5:FurnitureFittings2024-09-3004345156ns5:FurnitureFittings2023-09-3004345156ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-3004345156ns5:WithinOneYearns5:CurrentFinancialInstruments2023-09-3004345156ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2024-09-3004345156ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2023-09-3004345156ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-09-3004345156ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2023-09-3004345156ns5:WithinOneYear2024-09-3004345156ns5:WithinOneYear2023-09-3004345156ns5:AcceleratedTaxDepreciationDeferredTax2024-09-3004345156ns5:AcceleratedTaxDepreciationDeferredTax2023-09-3004345156ns5:DeferredTaxation2023-09-3004345156ns5:OtherProvisionsContingentLiabilities2023-09-3004345156ns5:DeferredTaxation2023-10-012024-09-3004345156ns5:OtherProvisionsContingentLiabilities2023-10-012024-09-3004345156ns5:DeferredTaxation2024-09-3004345156ns5:OtherProvisionsContingentLiabilities2024-09-3004345156ns10:OrdinaryShareClass12024-09-3004345156ns5:OtherRelatedParties2023-10-012024-09-30
REGISTERED NUMBER: 04345156 (England and Wales)















STRATEGIC REPORT, REPORT OF THE DIRECTORS AND

FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2024

FOR

PROHEALTHCARE LIMITED

PROHEALTHCARE LIMITED (REGISTERED NUMBER: 04345156)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024










Page

Company Information 1

Strategic Report 2

Report of the Directors 3

Report of the Independent Auditors 5

Income Statement 8

Other Comprehensive Income 9

Statement of Financial Position 10

Statement of Changes in Equity 11

Statement of Cash Flows 12

Notes to the Statement of Cash Flows 13

Notes to the Financial Statements 14


PROHEALTHCARE LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 SEPTEMBER 2024







DIRECTORS: J A Plinston
P Lawrence
A A Vaughan
A Hearne



SECRETARY: Z Gibbs



REGISTERED OFFICE: 15 Wheatstone Court
Waterwells Business Park
Quedgeley
Gloucester
Gloucestershire
GL2 2AQ



BUSINESS ADDRESS: Delta Lake Enterprise Centre
The Avenue
Delta Lakes
Llanelli
SA15 2DR



REGISTERED NUMBER: 04345156 (England and Wales)



AUDITORS: GKP (Ampthill) Limited
3 Doolittle Yard
Froghall Road
Ampthill
Bedfordshire
MK45 2NW

PROHEALTHCARE LIMITED (REGISTERED NUMBER: 04345156)

STRATEGIC REPORT
FOR THE YEAR ENDED 30 SEPTEMBER 2024


The directors present their strategic report for the year ended 30 September 2024.

The purpose of the Strategic Report is to inform shareholders and help them to assess how the directors have performed their duties to promote the success of the company. The report, together with the further information in the Directors' Report, provides a fair and balanced review of the company's business including; the development and performance of the business during the year, the position of the company at the end of the year and a description of the principal risks and uncertainties facing the company.

REVIEW OF BUSINESS
Turnover decreased by approximately 4.36% and our gross margin percentage decreased to 21.45% (2023 21.48%). In 2024 the company produced a profit before taxation of £309,977 (2023 £333,842) and the position of the company at the year end was stable.

PRINCIPAL RISKS AND UNCERTAINTIES
The principal risk facing the company continues to be that it is dependent on a strong economy. We primarily supply specialist mental health nurses to the NHS and private hospitals. We, therefore, rely on there being adequate demand and growth in the economy so that these essential services are properly funded. There is further uncertainty from potential ongoing changes in government policy and legislation. The company makes little use of financial instruments other than operational bank accounts and an invoice discounting facility, so its exposure to price risk, liquidity risk and cash flow risk is not material for the assessment of the assets, liabilities, financial position and profit and loss of the company. All customers who wish to trade on credit terms are subject to credit verification procedures. Receivables balances are monitored on an ongoing basis and provisions made for doubtful debts where necessary. The company maintains debt insurance through a group policy organised by the holding company.

KEY PERFORMANCE INDICATORS
These revolve around gross profit, staff productivity ratios and adjusted EBITA. The comparison of these ratios with the previous year is set out below.

2024 2023

Gross profit percentage 21.45 21.48
Adjusted EBITA £319,879 £339,200
Staff productivity £3.30 £3.57

ON BEHALF OF THE BOARD:





J A Plinston - Director


25 June 2025

PROHEALTHCARE LIMITED (REGISTERED NUMBER: 04345156)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 30 SEPTEMBER 2024


The directors present their report with the financial statements of the company for the year ended 30 September 2024.

PRINCIPAL ACTIVITY
The principal activity of the company in the year under review was that of a recruitment agency for the nursing profession.

DIVIDENDS
An interim dividend of £4,500 per share was paid on the ordinary £1 shares (£6,300 September 2023).
The directors recommend that no final dividend be paid on these shares.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 October 2023 to the date of this report.

J A Plinston
P Lawrence
A A Vaughan
A Hearne

Mr P Lawrence and Mr J A Plinston are also directors and shareholders of Opera Holdings Limited, the ultimate parent company.

FUTURE DEVELOPMENTS
The directors expect continued profitability for the foreseeable future.

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-state whether applicable accounting standards have been followed, subject to any material departures disclosed and
explained in the financial statements;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

PROHEALTHCARE LIMITED (REGISTERED NUMBER: 04345156)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 30 SEPTEMBER 2024


STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

ON BEHALF OF THE BOARD:





J A Plinston - Director


25 June 2025

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
PROHEALTHCARE LIMITED


Opinion
We have audited the financial statements of ProHealthCare Limited (the 'company') for the year ended 30 September 2024 which comprise the Income Statement, Other Comprehensive Income, Statement of Financial Position, Statement of Changes in Equity, Statement of Cash Flows and Notes to the Statement of Cash Flows, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 30 September 2024 and of its profit for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
PROHEALTHCARE LIMITED


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page three, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

- A part of the audit planning process was to look at each area of the financial statements and ascertain the level of risk for each applicable audit assertion. Where an increased risk was identified, specific audit work was designed to ensure those risks were at the forefront of the audit work carried out.
- During the audit planning process, important laws and regulations applying to the company were identified by making enquiries of management in addition to our own checks of the laws and regulations applying to a business of this nature.
- The audit process has documented the systems and internal controls adopted by the company and considered their adequacy. Our audit work included testing journal entries due to an inherent risk of management override of controls.
- An audit team planning meeting was held which communicated areas of identified risks and considered possible opportunities for fraud within the company.
- The engagement partner assessed the experience and abilities of the engagement team to ensure they were collectively competent to identify irregularities.
- All risks identified at the planning stage and the related audit work were reviewed and results considered to confirm that no irregularities had been identified.
- Our audit has included a review of the disclosures in the financial statements and comparison of those disclosures with the results of our audit work to identify any disparities.
- Analytical review of the financial statements has been undertaken at both the planning and completion stages of the audit to identify risks of irregularities and the results of the audit work carried out on those areas of risks.
- The judgements made in making accounting estimates have been assessed as to whether they indicate potential bias.
- Enquiries have been made of management regarding known instances of fraud, litigation or claims in progress.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
PROHEALTHCARE LIMITED


Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Karen Dyer FCCA (Senior Statutory Auditor)
for and on behalf of GKP (Ampthill) Limited
Statutory Auditor
3 Doolittle Yard
Froghall Road
Ampthill
Bedfordshire
MK45 2NW

25 June 2025

PROHEALTHCARE LIMITED (REGISTERED NUMBER: 04345156)

INCOME STATEMENT
FOR THE YEAR ENDED 30 SEPTEMBER 2024

2024 2023
Notes £    £   

TURNOVER 2,642,417 2,763,047

Cost of sales 2,075,701 2,169,452
GROSS PROFIT 566,716 593,595

Administrative expenses 246,837 254,395
OPERATING PROFIT 4 319,879 339,200


Interest payable and similar expenses 5 9,901 5,358
PROFIT BEFORE TAXATION 309,978 333,842

Tax on profit 6 36,538 72,571
PROFIT FOR THE FINANCIAL YEAR 273,440 261,271

PROHEALTHCARE LIMITED (REGISTERED NUMBER: 04345156)

OTHER COMPREHENSIVE INCOME
FOR THE YEAR ENDED 30 SEPTEMBER 2024

2024 2023
Notes £    £   

PROFIT FOR THE YEAR 273,440 261,271


OTHER COMPREHENSIVE INCOME - -
TOTAL COMPREHENSIVE INCOME
FOR THE YEAR

273,440

261,271

PROHEALTHCARE LIMITED (REGISTERED NUMBER: 04345156)

STATEMENT OF FINANCIAL POSITION
30 SEPTEMBER 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 9 - 110

CURRENT ASSETS
Debtors 10 255,264 187,101
Cash at bank 440 1,349
255,704 188,450
CREDITORS
Amounts falling due within one year 11 187,868 158,768
NET CURRENT ASSETS 67,836 29,682
TOTAL ASSETS LESS CURRENT
LIABILITIES

67,836

29,792

CREDITORS
Amounts falling due after more than one year 12 (7,500 ) (17,500 )

PROVISIONS FOR LIABILITIES 15 (6,452 ) (6,848 )
NET ASSETS 53,884 5,444

CAPITAL AND RESERVES
Called up share capital 16 50 50
Capital redemption reserve 50 50
Retained earnings 53,784 5,344
SHAREHOLDERS' FUNDS 53,884 5,444

The financial statements were approved by the Board of Directors and authorised for issue on 25 June 2025 and were signed on its behalf by:





J A Plinston - Director


PROHEALTHCARE LIMITED (REGISTERED NUMBER: 04345156)

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 30 SEPTEMBER 2024

Called up Capital
share Retained redemption Total
capital earnings reserve equity
£    £    £    £   
Balance at 1 October 2022 50 59,073 50 59,173

Changes in equity
Dividends - (315,000 ) - (315,000 )
Total comprehensive income - 261,271 - 261,271
Balance at 30 September 2023 50 5,344 50 5,444

Changes in equity
Dividends - (225,000 ) - (225,000 )
Total comprehensive income - 273,440 - 273,440
Balance at 30 September 2024 50 53,784 50 53,884

PROHEALTHCARE LIMITED (REGISTERED NUMBER: 04345156)

STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

2024 2023
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 297,282 378,563
Interest paid (9,901 ) (5,358 )
Tax paid (53,290 ) (47,494 )
Net cash from operating activities 234,091 325,711

Cash flows from financing activities
Loan repayments in year (10,000 ) (10,000 )
Equity dividends paid (225,000 ) (315,000 )
Net cash from financing activities (235,000 ) (325,000 )

(Decrease)/increase in cash and cash equivalents (909 ) 711
Cash and cash equivalents at beginning of
year

2

1,349

638

Cash and cash equivalents at end of year 2 440 1,349

PROHEALTHCARE LIMITED (REGISTERED NUMBER: 04345156)

NOTES TO THE STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 30 SEPTEMBER 2024


1. RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS

2024 2023
£    £   
Profit before taxation 309,978 333,842
Depreciation charges 110 329
Movement in dilapidations provision (372 ) 2,732
Finance costs 9,901 5,358
319,617 342,261
(Increase)/decrease in trade and other debtors (68,163 ) 145,200
Increase/(decrease) in trade and other creditors 45,828 (108,898 )
Cash generated from operations 297,282 378,563

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Statement of Cash Flows in respect of cash and cash equivalents are in respect of these Statement of Financial Position amounts:

Year ended 30 September 2024
30.9.24 1.10.23
£    £   
Cash and cash equivalents 440 1,349
Year ended 30 September 2023
30.9.23 1.10.22
£    £   
Cash and cash equivalents 1,349 638


3. ANALYSIS OF CHANGES IN NET DEBT

At 1.10.23 Cash flow At 30.9.24
£    £    £   
Net cash
Cash at bank 1,349 (909 ) 440
1,349 (909 ) 440
Debt
Debts falling due within 1 year (10,000 ) - (10,000 )
Debts falling due after 1 year (17,500 ) 10,000 (7,500 )
(27,500 ) 10,000 (17,500 )
Total (26,151 ) 9,091 (17,060 )

PROHEALTHCARE LIMITED (REGISTERED NUMBER: 04345156)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024


1. STATUTORY INFORMATION

ProHealthCare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The directors have considered all relevant matters and believe that the going concern basis continues to be appropriate when preparing these accounts.

Turnover
Turnover represents the net invoiced sales of services, stated after trade discounts, other sales taxes and net of VAT. Revenue from the supply of temporary workers is recognised based on the hours worked each week.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures, fittings & equipment - 33% on cost and 20% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Hire purchase and leasing commitments
Rentals payable under operating leases are charged against income on a straight line basis over the lease term.

PROHEALTHCARE LIMITED (REGISTERED NUMBER: 04345156)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


2. ACCOUNTING POLICIES - continued

Holiday pay accrual
A liability is recognised to the extent of any unused holiday pay entitlement which has accrued at the balance sheet date and carried forward to future periods. This is measured at the undiscounted salary cost of the future holiday entitlement so accrued at the balance sheet date.

Financial instruments
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

3. EMPLOYEES AND DIRECTORS
2024 2023
£    £   
Wages and salaries 157,255 153,686
Social security costs 11,720 9,978
Other pension costs 2,633 2,440
171,608 166,104

The average number of employees during the year was as follows:
2024 2023

Administration 4 5
Sales 4 4
8 9

2024 2023
£    £   
Directors' remuneration 33,505 34,076
Directors' pension contributions to money purchase schemes 442 460

The number of directors to whom retirement benefits were accruing was as follows:

Money purchase schemes 1 1

PROHEALTHCARE LIMITED (REGISTERED NUMBER: 04345156)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


4. OPERATING PROFIT

The operating profit is stated after charging:

2024 2023
£    £   
Depreciation - owned assets 110 329
Auditors' remuneration 4,800 4,750
Operating lease rentals - land & buildings 6,791 10,943

5. INTEREST PAYABLE AND SIMILAR EXPENSES
2024 2023
£    £   
Bank loan interest 579 823
Invoice discounting interest 8,527 4,535
Other interest 795 -
9,901 5,358

6. TAXATION

Analysis of the tax charge
The tax charge on the profit for the year was as follows:
2024 2023
£    £   
Current tax:
UK corporation tax 35,902 72,630
Corporation tax prior year
adjustment 660 -
Total current tax 36,562 72,630

Deferred tax (24 ) (59 )
Tax on profit 36,538 72,571

UK corporation tax has been charged at 25% (2023 - 22.01%).

PROHEALTHCARE LIMITED (REGISTERED NUMBER: 04345156)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


6. TAXATION - continued

Reconciliation of total tax charge included in profit and loss
The tax assessed for the year is lower than the standard rate of corporation tax in the UK. The difference is explained below:

2024 2023
£    £   
Profit before tax 309,978 333,842
Profit multiplied by the standard rate of corporation tax in the UK of 25%
(2023 - 25%)

77,495

83,461

Effects of:
Depreciation in excess of capital allowances 27 82
(Decrease)/Increase in deferred tax provision (24 ) (59 )
Loss surrendered by parent/subsidiary company - (289 )
Charged at different rate - (10,624 )
Prior year adjustment 660 -
Loss surrendered by parent company (41,620 ) -
Total tax charge 36,538 72,571

7. DIVIDENDS
2024 2023
£    £   
Interim 225,000 315,000

8. PRIOR YEAR ADJUSTMENT

The company has revised its interpretation of the contracts with agency workers, which had the impact of removing the associated costs and average employee numbers from the disclosure in note 3. Wages and salaries costs and social security costs previously disclosed were reduced by £1,968,083 and £193,241 respectively. Average employee numbers reduced by 39.

PROHEALTHCARE LIMITED (REGISTERED NUMBER: 04345156)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


9. TANGIBLE FIXED ASSETS
Fixtures,
fittings
& equipment
£   
COST
At 1 October 2023
and 30 September 2024 16,367
DEPRECIATION
At 1 October 2023 16,257
Charge for year 110
At 30 September 2024 16,367
NET BOOK VALUE
At 30 September 2024 -
At 30 September 2023 110

10. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 212,980 154,003
Amounts due from group
undertakings 40,690 25,628
Prepayments 1,594 7,470
255,264 187,101

The company is part of a receivables finance agreement with Lloyds Commercial Finance Limited together with the following group companies: Opera Holdings Limited, Richmond Support Services Limited (formerly Workworld Limited), The Workbank Recruitment Consultancy Limited, Total Staff Services UK Limited, Freight Personnel Limited, Staff Call Recruitment Specialists Limited and Richmond Nursing Agency Limited. The amount due is reflected in the accounts of Opera Holdings Limited, the ultimate parent company which administers the agreement. The monies advanced to the group are secured by a debenture giving a fixed and floating charge on each company's assets. Each company has a cross guarantee with the other companies covered by the agreement

11. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts (see note 13) 10,000 10,000
Trade creditors 827 546
Corporation tax 55,902 72,630
Social security and other taxes 75,442 39,500
Other creditors 32,163 19,587
Accrued expenses 13,534 16,505
187,868 158,768

PROHEALTHCARE LIMITED (REGISTERED NUMBER: 04345156)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


12. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
£    £   
Bank loans (see note 13) 7,500 17,500

13. LOANS

An analysis of the maturity of loans is given below:

2024 2023
£    £   
Amounts falling due within one year or on demand:
Bank loans 10,000 10,000

Amounts falling due between one and two years:
Bank loans - 1-2 years 7,500 10,000

Amounts falling due between two and five years:
Bank loans - 2-5 years - 7,500

The bank loan has been taken out under the Bounce Back Loan Scheme. The loan is repayable monthly over five years from June 2021 and the interest charged is 2.5 per cent per annum.

14. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
2024 2023
£    £   
Within one year - 6,667

15. PROVISIONS FOR LIABILITIES
2024 2023
£    £   
Deferred tax
Accelerated capital allowances - 24
Dilapidations 6,452 6,824
6,452 6,848

PROHEALTHCARE LIMITED (REGISTERED NUMBER: 04345156)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


15. PROVISIONS FOR LIABILITIES - continued

Deferred Dilapid-
tax ations
£    £   
Balance at 1 October 2023 24 6,824
Credit to Income Statement during year (24 ) (372 )
Balance at 30 September 2024 - 6,452

The provision against dilapidations relates to the estimated claim for dilapidations of a leasehold property exited during the year. The claim was in negotiations and had not concluded by the year end.

16. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
50 Ordinary £1 50 50

The ordinary shares have attached to them full voting, dividend and capital distribution rights.

17. ULTIMATE PARENT COMPANY

The ultimate parent company is Opera Holdings Limited a company incorporated in England and Wales and whose registered office is at 15 Wheatstone Court, Waterwells Business Park, Quedgeley, Gloucester GL2 2AQ.

Group accounts are prepared and are available from the registered office.

18. RELATED PARTY DISCLOSURES

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Other related parties

The company recharged costs of £161,322 (2023 £22,042) to Richmond Nursing Agency Limited, an 87.5% owned subsidiary of the parent company. Richmond Nursing Agency recharged £145,471 (2023 £10,191) of costs to Prohealthcare Limited. Any amounts owing are interest free and are repayable on demand. In addition, the company made interest free loans to Richmond Nursing Agency Limited during the year and the total amount owing to Richmond Nursing Agency at 30 September 2024 was £4,093 (2023: £4,306 owed to ProHealthCare).